%PDF-1.4
%
1 0 obj
<>>>
endobj
2 0 obj
<>stream
2017-10-14T12:10+05:30
2017-10-14T12:10:06+05:30
2017-10-14T12:10:06+05:30
Adobe InDesign CS6 (Macintosh)
uuid:cfb3671c-4615-af43-9108-fbe47f9137ca
xmp.did:01801174072068118DBB881A9EDFAAFA
xmp.id:110B3C8C0E206811822AC5CD1C338185
proof:pdf
converted
from application/x-indesign to application/pdf
Adobe InDesign CS6 (Macintosh)
/
2017-10-14T12:10+05:30
xmp.iid:2D246DD30C206811822AC5CD1C338185
xmp.did:01801174072068118DBB881A9EDFAAFA
xmp.did:01801174072068118DBB881A9EDFAAFA
default
application/pdf
Adobe PDF Library 10.0.1
False
endstream
endobj
5 0 obj
<>
endobj
3 0 obj
<>
endobj
7 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
8 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
9 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
10 0 obj
<>/Font<>/ProcSet[/PDF/Text/ImageC]/Properties<>/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
11 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
12 0 obj
<>/Font<>/ProcSet[/PDF/Text]/XObject<>>>/TrimBox[9.0 9.0 621.0 801.0]/Type/Page>>
endobj
51 0 obj
<>stream
q
/GS0 gs
/Fm0 Do
Q
BT
0 0 0 1 k
/GS1 gs
/T1_0 1 Tf
11 0 0 11 573.9999 54.4294 Tm
(31)Tj
ET
q
0 g
/GS0 gs
/Fm1 Do
Q
0 0 0 1 K
q 1 0 0 1 45 341.9917 cm
0 0 m
258 0 l
S
Q
q 1 0 0 1 45 185.9917 cm
0 0 m
258 0 l
S
Q
BT
/C2_0 1 Tf
-0.01 Tc 0.01 Tw 11 0 0 11 45 697.9917 Tm
[<005700520003>-191.4<00440003>-191.4<0046005200500045004C005100440057004C005200510003>-191.4<005200490003>-191.4<00590044004F00590058004F004400550003>-191.4<005600570048005100520056004C00560003>-191.4<0044005100470003>-191.4<00550048004A00580055004A004C00570044>]TJ
0 Tc 0 Tw <0010>Tj
-0.01 Tc 0.01 Tw 0 -1.182 TD
[<0057004C0052005100110003>22<002F0048004900570003>22.1<0056004C0047004800470003>22<0046004400550047004C004400460003>22<004C005100590052004F0059004800500048005100570003>22<0052004600460058005500560003>22<004C00510003>22<004F0048005600560003>22<0057004B00440051>-10.1<0003>]TJ
T*
[<0014001300080003>-235.1<005200490003>-235.1<005300440057004C004800510057005600110003>-235.2<002B0052005A0048005900480055>55.1<000F0003>-235.1<005A004B004800510003>-235.1<0057004B00480003>-235.1<00530055004C005000440055005C0003>-235.1<0046004400550046004C>]TJ
0 Tc 0 Tw <0010>Tj
-0.01 Tc 0.01 Tw 0 -1.182 TD
[<00510052004C00470003>-97<005700580050005200550003>-97<00440055004C0056004800560003>-96.9<004C00510003>-97<00440003>-97<00530058004F00500052005100440055005C0003>-97<00450055005200510046004B00580056000F0003>-97<0057004B004C00560003>-97<00500044005C>-10<0003>]TJ
/TT0 1 Tf
0.055 Tw 0 -1.182 TD
[(result )0.5(in )0.5(the )0.5(involvement )0.5(of )0.5(the )0.5(left )0.5(sided )0.5(heart )0.5(valves)-10( )]TJ
/C2_0 1 Tf
0.01 Tw T*
[<00520051004F005C>74.3<00110003>-75.2<0037004B00480003>-93.3<005300550048005600480051004600480003>-93.3<005200490003>-93.3<004500520057004B0003>-93.2<004F0048004900570003>-93.3<0044005100470003>-93.3<0055004C004A004B00570003>-93.2<0056004C0047004800470003>-93.3<00590044004F00590058>]TJ
0 Tc 0 Tw <0010>Tj
-0.01 Tc 0.01 Tw T*
[<004F004400550003>-78<0047004C005600480044005600480003>-78<004C00510003>-78<0057004B00480003>-78<00460052005100570048005B00570003>-77.9<005200490003>-78<004A00440056005700550052004C00510057004800560057004C00510044004F0003>-77.9<0046004400550046004C00510052004C0047>-10.1<0003>]TJ
T*
[<004C00560003>-151.6<00440056005600520046004C00440057004800470003>-151.6<005A004C0057004B0003>-151.7<004500520057004B0003>-151.7<0056004800590048005500480003>-151.7<0044005100470003>-151.6<0053005200520055004F005C0003>-151.7<004600520051005700550052004F004F00480047>-10.2<0003>]TJ
T*
[<0047004C0056004800440056004800110003>5.6<003800530003>5.6<005700520003>5.6<001700080003>5.6<005200490003>5.6<0057004B0048005600480003>5.6<004600440056004800560003>5.6<0046004400510003>5.6<004B0044005900480003>5.6<00500048005700440056005700440057004C0046>-10<0003>]TJ
0 -1.182 TD
[<0047004C005600480044005600480003>-62.1<005200510003>-62<0057004B00480003>-62<00590044004F005900480056000F0003>-62<0044005100470003>-62<00160011001B00080003>-62<004B0044005900480003>-62<0047004C00550048004600570003>-62<0050005C0052004600440055>]TJ
0 Tc 0 Tw <0010>Tj
/TT0 1 Tf
-0.01 Tc -0.02 Tw 0 -1.182 TD
(dial involvement.)Tj
0.01 Tw 6.82 0 0 6.82 124.8393 572.1717 Tm
(14)Tj
/TT1 1 Tf
0 Tc 0 Tw ( )Tj
/C2_0 1 Tf
-0.01 Tc 0.01 Tw 11 0 0 11 133.9781 567.9917 Tm
[<003600580055004A004C00460044004F0003>20.4<00590044004F005900480003>20.3<005500480053004F00440046004800500048005100570003>20.3<004C00510003>20.3<0057004B004800560048>-10.1<0003>]TJ
-8.089 -1.182 Td
[<005300440057004C00480051005700560003>-7.9<004B004400560003>-7.9<00440003>-7.9<001600130003>-7.9<00470044005C0003>-7.9<00500052005500570044004F004C0057005C0003>-7.9<005200490003>-7.9<0014001A00080003>-7.9<000B005500440051004A00480003>-7.9<00140010001900160008000C000F>-9.9<0003>]TJ
T*
[<0045005800570003>-84.3<004F00520051004A001000570048005500500003>-84.2<0056005800550059004C00590052005500560003>-84.2<004F004C005900480003>-84.3<004400510003>-84.3<00440059004800550044004A00480003>-84.2<005200490003>-84.2<0018001B0003>-84.3<0050005200510057004B0056>-9.9<0003>]TJ
0 -1.182 TD
[<004400490057004800550003>-111.5<005600580055004A00480055005C>74.2<00110003>-111.5<0026004F004C0051004C00460044004F0003>-111.5<0056005700580047004C004800560003>-111.5<004700480050005200510056005700550044005700480003>-111.5<0057004B004400570003>-111.5<005600580055004A004C>]TJ
0 Tc 0 Tw <0010>Tj
-0.01 Tc 0.01 Tw 0 -1.182 TD
[<00460044004F0003>-138.3<004C00510057004800550059004800510057004C005200510003>-138.3<004C00500053005500520059004800560003>-138.3<0057004B00480003>-138.3<005300550052004A005100520056004C00560003>-138.2<0044005100470003>-138.3<0055004800470058004600480056>-10<0003>]TJ
T*
[<0056005C0050005300570052005000560003>-116.2<005200490003>-116.2<004B00480044005500570003>-116.2<00490044004C004F00580055004800110003>-116.2<00330052005600570010005200530048005500440057004C005900480003>-116.2<00500052005500570044004F004C0057005C0003>-116.2<004C0056>-9.9<0003>]TJ
/TT0 1 Tf
0 Tw T*
(mainly due to the carcinoid disease itself.)Tj
0.01 Tw 6.82 0 0 6.82 240.8213 494.1717 Tm
(15,16)Tj
0 Tc 0 Tw 11 0 0 11 257.6151 489.9917 Tm
( )Tj
ET
q
0 0 630 810 re
W n
BT
/TT2 1 Tf
/Span<>> BDC
14 0 0 14 45 465.9917 Tm
(C)Tj
EMC
9.8 0 0 9.8 55.1104 465.9917 Tm
(ONCLUS)Tj
/Span<>> BDC
(I)Tj
EMC
(ON)Tj
ET
Q
BT
/C2_0 1 Tf
11 0 0 11 63 441.9917 Tm
[<0032005800550003>-91.2<00460044005600480003>-91.6<00550048005300550048005600480051005700560003>-91.9<004400510003>-91.5<005800510058005600580044004F0003>-92.2<0044005100470003>-91.7<004800440055004F005C0003>-91.8<0053005500480056>]TJ
<0010>Tj
-1.636 -1.182 Td
[<00480051005700440057004C005200510003>127<005200490003>127.5<0046004400550046004C00510052004C00470003>126.6<0056005C0051004700550052005000480003>126.9<004C00510003>127.3<00440003>127.3<0015001A0010005C00480044005500100052004F00470003>126.5<005A00520050004400510003>]TJ
T*
[<005A004B00520003>39.8<004B004400470003>40.1<0056004800590048005500480003>40.2<00530058004F00500052005100440055005C>-1<0003>40.3<0044005100470003>39.8<00570055004C0046005800560053004C00470003>39.7<0047004C005600480044005600480003>39.5<005A004C0057004B0003>]TJ
0 -1.182 TD
[<0055004C004A004B00570003>-41.5<004400570055004C0044004F0003>-41.6<00480051004F00440055004A004800500048005100570003>-42.2<004400570003>-41.1<0057004B00480003>-41.3<0057004C005000480003>-41.3<005200490003>-41.2<0047004C0044004A005100520056004C005600110003>-42<0036004B00480003>]TJ
0 -1.182 TD
[<00580051004700480055005A0048005100570003>-477.5<005600580046004600480056005600490058004F0003>-477.1<00590044004F00590058004F004400550003>-477.5<005500480053004F004400460048005000480051005700110003>-459.3<0037004B004C00560003>]TJ
T*
[<00460044005600480003>-49.2<00530055005200500053005700560003>-49.1<005800560003>-49<005700520003>-48.8<004B0044005900480003>-49.4<00440003>-48.9<004B004C004A004B004800550003>-49.6<004C005100470048005B0003>-49.5<005200490003>-48.9<0056005800560053004C0046004C005200510003>]TJ
T*
<00490052005500030057004B004C005600030047004C0044004A005100520056004C005600110003>Tj
/TT1 1 Tf
10.25 0 0 10.25 45 323.4917 Tm
(Article citation:)Tj
/TT0 1 Tf
( )Tj
/C2_0 1 Tf
10.5 0 0 10.5 122.4556 323.4917 Tm
[<002D0058004400550048005D00030028000F0003>55.2<00240047004C004A00440003>54.7<0024000F00030036004400510046004B0048005D00030033>128.9<000F0003>]TJ
-7.377 -1.19 Td
<002900440051004400560046004B0003002B0011000300300048005700440056005700440057004C004600030046004400550046004C00510052004C00470003005700580050005200550003005A004C0057004B00030056004800590048005500480003>Tj
0 -1.19 TD
<0047005200580045004F0048000300590044004F0059004800030047004C0056004800440056004800030044005700030047004C0044004A005100520056004C0056001D00030046004400560048000300550048005300520055005700030044005100470003>Tj
0 -1.19 TD
[<005500480059004C0048005A0003005200490003004F004C0057004800550044005700580055004800110003>17.5<0037004B004800030036005200580057004B005A00480056005700030035004800560053004C00550044005700520055005C00030044005100470003>]TJ
0 -1.19 TD
<00260055004C0057004C00460044004F0003002600440055004800030026004B005500520051004C0046004F004800560003001500130014001A001E00150014001D0015001900B100160014>Tj
/TT1 1 Tf
10.25 0 0 10.25 45 260.9917 Tm
(From:)Tj
/C2_0 1 Tf
10.5 0 0 10.5 74.0383 260.9917 Tm
[<000300270048005300440055005700500048005100570003005200490003002C005100570048005500510044004F0003003000480047004C0046004C00510048000F0003>17.1<0037>111<0048005B004400560003>17.9<0037>111<00480046004B0003>]TJ
-2.766 -1.19 Td
[<00380051004C0059004800550056004C0057005C0003002B00480044004F0057004B000300360046004C004800510046004800560003002600480051005700480055>53.3<000F0003002F00580045004500520046004E000F0003>18<0037003B>]TJ
/TT1 1 Tf
10.25 0 0 10.25 45 235.9917 Tm
(Submitted: )Tj
/TT0 1 Tf
10.5 0 0 10.5 101.37 235.9917 Tm
(5/12/2017)Tj
/TT1 1 Tf
10.25 0 0 10.25 45 223.4917 Tm
(Accepted: )Tj
/C2_0 1 Tf
10.5 0 0 10.5 97.4011 223.4917 Tm
<001C0012001600130012001500130014001A>Tj
/TT1 1 Tf
10.25 0 0 10.25 45 210.9917 Tm
(Reviewer: )Tj
/C2_0 1 Tf
10.5 0 0 10.5 96.275 210.9917 Tm
<002E00480051005100480057004B000300310058004A004800510057000300300027>Tj
/C2_1 1 Tf
10.25 0 0 10.25 45 198.4917 Tm
<00260052005100C0004C0046005700560003005200490003004C0051005700480055004800560057001D>Tj
/TT0 1 Tf
( none)Tj
ET
q
0 0 630 810 re
W n
BT
/T1_1 1 Tf
13 0 0 13 45 154.4917 Tm
(R)Tj
9.1 0 0 9.1 53.6709 154.4917 Tm
(EFE)Tj
/Span<>> BDC
(R)Tj
EMC
(ENCES)Tj
ET
Q
BT
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
10 0 0 10 45 129.4917 Tm
( )Tj
EMC
[(1)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.163 Tw 1.8 0 Td
[(P)14.9(apaxoinis G, Syrigos K, Saif MW)150(. Ne)25(w concepts in the )]TJ
0.189 Tw 0 -1.2 TD
[(treatment )0.5(strate)14.9(gy of )0.5(neuroendocrine )0.5(tumors: )50.3(The role )0.5(of )]TJ
0 Tw T*
[(biotherap)29.8(y)85(. Disco)44.9(v Med 2016; 21\(117\): 381\2269.)]TJ
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
26.4 59.267 Td
( )Tj
EMC
[(2)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.065 Tw 1.8 0 Td
[(K)24.9(unz PL. Carcinoids and neuroendocrine tumors: Building )]TJ
0 Tw 0 -1.211 TD
(on success. J Clin Oncol 2015; 1; 33\(16\):1855\22663.)Tj
/T1_0 1 Tf
-0.02 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.211 Td
( )Tj
EMC
[(3)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0.01 Tc 0.092 Tw 1.8 0 Td
[(Y)139.9(ao JC, Hassan M, Phan )55.1(A, Dagoho)45(y C, Lear)-19.8(y C, Mares)10( )]TJ
-0.001 Tw T*
[(JE, )54.7(Abdalla EK, Fleming JB)29.8(, )49.5(V)110.9(authe)14.9(y JN)24.9(, Rashid )54.7(A, Ev)24.9(ans)10( )]TJ
0.357 Tw T*
[(DB)29.8(. )0.5(One )0.5(hundred )0.5(y)19.8(ears )0.6(after )0.5(\223carcinoid\224: )0.5(Epidemiol)]TJ
0 Tc 0 Tw (-)Tj
0.01 Tc 0.124 Tw T*
[(o)24.9(gy of and pro)24.9(gnostic f)-9.8(actors for neuroendocrine tumors)10( )]TJ
0.112 Tw T*
[(in 35,825 cases in the United States. J Clin Oncol 2008;)10( )]TJ
-0.01 Tw T*
(26\(18\):3063\2263072.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.211 Td
( )Tj
EMC
[(4)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.131 Tw 1.8 0 Td
[(Mocellin )0.5(S, )0.5(Nitti )0.5(D)59.9(. Gastrointestinal )0.6(carcinoid: )0.6(Epidemio)]TJ
0 Tw (-)Tj
0.019 Tw T*
[(lo)24.9(gical and sur)-19.7(vi)24.9(v)24.9(al e)24.9(vidence from a lar)17.8(ge population-based )]TJ
0 Tw 0 -1.211 TD
[(study \(n = 25 531\). )55(Ann Oncol 2013; 24\(12\):3040\2264.)]TJ
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.211 Td
( )Tj
EMC
[(5)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.039 Tw 1.8 0 Td
[(\326ber)17.9(g K. Neuroendocrine g)4.8(astro-enteropancreatic tumors \226 )]TJ
-0.01 Tw 0 -1.211 TD
[(from eminence based to e)24.9(vidence-based medicine \226 )54.9(A Scan)]TJ
0 Tw (-)Tj
0 -1.211 TD
[(dina)34.9(vian vie)25(w)89.8(. Scand J Gastroenterol 2015; 50\(6\): 727\22639.)]TJ
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.211 Td
( )Tj
EMC
[(6)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc -0.021 Tw 1.8 0 Td
[(K)24.9(ulk)9.8(e MH, Siu LL, )50.1(T)99.9(epper JE, F)19.8(isher G, Jaf)24.9(fe D)59.8(, Haller DG, )]TJ
0.187 Tw 0 -1.211 TD
[(Benedetti )0.5(JK, )0.5(Ber)17.8(gsland )0.5(EK, )0.5(Hobda)35(y )50.2(TJ)59.9(, )50.2(V)110.9(an )0.5(Cutsem )0.5(E, )]TJ
0.01 Tw T*
[(Pinkpank J)59.8(, \326ber)17.9(g K, Cohen SJ)59.8(, P)39.8(osner MC, )89.6(Y)139.9(ao JC. Future )]TJ
0.06 Tw T*
(directions in the treatment of neuroendocrine tumors: Con)Tj
0 Tw (-)Tj
0.121 Tw T*
[(sensus repor)-19.7(t of the National Cancer Institute Neuroendo)]TJ
0 Tw (-)Tj
0.118 Tw T*
[(crine )50.1(T)85(umor clinical trials planning meeting. J Clin Oncol )]TJ
0 Tw T*
(2011; 29\(7\): 934\22643.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.211 Td
( )Tj
EMC
[(7)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.053 Tw 1.8 0 Td
[(Kl\366ppel G, P)39.8(er)-29.8(ren )54.7(A, Heitz PU)79.8(. )49.6(The g)4.9(astroenteropancreatic )]TJ
0.045 Tw T*
[(neuroendocrine cell system and its tumors: )49.6(The )29.5(WHO clas)]TJ
0 Tw (-)Tj
T*
[(si\036cation. )55(Ann N )89.8(Y )55(Acad Sci. 1014: 13\22627, 2004.)]TJ
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.211 Td
( )Tj
EMC
[(8)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc 0.092 Tw 1.8 0 Td
[(Modlin IM, Sandor )55.3(A. )55.2(An anal)24.9(ysis of 8305 cases of carci)]TJ
0 Tw (-)Tj
T*
(noid tumors. Cancer 1997;79\(4\): 813\22629.)Tj
/T1_0 1 Tf
-0.03 Tc 0.28 Tw /Span<>> BDC
-1.8 -1.211 Td
( )Tj
EMC
[(9)-30(.)]TJ
/Span<>> BDC
( )Tj
EMC
/T1_2 1 Tf
0 Tc -0.019 Tw 1.8 0 Td
[(Melmon KL, Sjoerdsma )54.6(A, Oates J)49.8(A, Laster L. )49.4(T)34.9(reatment of )]TJ
0.036 Tw 0 -1.211 TD
[(malabsor)-29.7(ption and diar)-29.7(rhea of the carcinoid syndrome with )]TJ
0 Tw 0 -1.211 TD
[(meth)29.8(yser)17.9(gide. Gastroenterol 1965; 48: 18\22624.)]TJ
/T1_0 1 Tf
-1.8 -1.211 Td
(10.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
0.112 Tw 0.58 0 Td
[(Melmon KL. )49.8(V)110.8(asoacti)25(v)14.9(e substances in the patho)24.9(genesis of )]TJ
0.044 Tw 0 -1.211 TD
[(mig)-19.8(raine headache, carcinoid syndrome and other diseases. )]TJ
0 Tw T*
(Headache 1965; 5\(3\): 87\2268.)Tj
/T1_0 1 Tf
-1.8 -1.211 Td
(11.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
-0.026 Tw 0.58 0 Td
[(Engelman )0.5(K, Lo)45(v)14.9(enber)17.8(g )30.2(W)150(, Sjoerdsma )55.4(A. )0.5(Inhibition of )0.5(sero)]TJ
0 Tw (-)Tj
-0.01 Tw T*
[(tonin synthesis b)24.9(y para-chlorophen)24.9(ylalanine in patients with )]TJ
0 Tw T*
(carcinoid syndrome. N Engl J Med 1967; 277\(21\): 1103\2268.)Tj
/T1_0 1 Tf
-1.8 -1.211 Td
(12.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
0.162 Tw 0.58 0 Td
[(Anderson )55.1(AS, Krauss D)59.8(, Lang R. Cardio)45(v)24.9(ascular compli)]TJ
0 Tw (-)Tj
0.14 Tw T*
[(cations of malignant carcinoid disease. )54.7(Am Hear)-19.7(t J 1977; )]TJ
0 Tw T*
(134\(4\):693\226702.)Tj
/T1_0 1 Tf
-1.8 -1.211 Td
(13.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
-0.031 Tw 0.58 0 Td
[(Ber)-19.8(nheim )54.7(AM, Conoll)24.9(y HM, Hobda)34.9(y )49.5(TJ)59.8(, P)39.8(ellikka P)119.9(A. Carci)]TJ
0 Tw (-)Tj
-0.053 Tw T*
[(noid hear)-19.7(t disease. Pro)24.9(g Cardio)44.9(v)24.9(asc Dis 2007; 49\(6\): 439-51.)]TJ
/T1_0 1 Tf
0 Tw -1.8 -1.211 Td
(14.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
0.31 Tw 0.58 0 Td
[(P)14.9(alanis)19.8(w)24.9(am)39.8(y C, F)19.8(rishman )30(WH, )55.2(Anoro)39.8(w )30(WS. Carcinoid )]TJ
0 Tw T*
[(hear)-19.7(t disease. Cardiol Re)25(v 2012; 20\(4\): 167\22676.)]TJ
/T1_0 1 Tf
-1.8 -1.211 Td
(15.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
-0.01 Tc 0.057 Tw 0.58 0 Td
[(Manol)25(y I, McAnell)24.9(y SL, Sriskandarajah S, McLaughlin KE.)-9.9( )]TJ
-0.03 Tw T*
[(Pro)24.9(gnosis of patients with carcinoid disease after v)24.9(alvular sur)]TJ
0 Tc 0 Tw 23.667 0 Td
(-)Tj
-0.01 Tc -23.667 -1.211 Td
[(ger)-19.7(y)84.9(. Interact Cardio)44.9(v)24.9(asc )49.8(Thorac Sur)17.8(g 2014; 19\(2\): 302\2265.)]TJ
/T1_0 1 Tf
0 Tc -1.8 -1.211 Td
(16.)Tj
/Span<>> BDC
1.22 0 Td
( )Tj
EMC
/T1_2 1 Tf
0.207 Tw 0.58 0 Td
[(Edw)24.9(ards NC, )89.7(Y)110.8(uan M, Nolan O)39.8(, P)14.9(a)39.8(w)24.9(ade )49.7(T)92.8(A, Oleofse )49.7(T)99.9(, )]TJ
0.094 Tw T*
[(Singh H, Mehrzad H, Zia Z, Geh JI, P)14.9(almer DH, Ma)34.9(y CJ)59.8(, )]TJ
0.142 Tw T*
[(A)91.8(yuk J)59.8(, Shah )49.7(T)99.8(, Roone)15(y SJ)59.8(, Steeds RP)160(. Ef)24.9(fect of v)24.9(alvular )]TJ
0.063 Tw T*
[(sur)17.8(ger)-19.7(y in carcinoid hear)-19.7(t disease: )55(An obser)-19.8(v)24.9(ational cohor)-19.8(t )]TJ
0 Tw T*
[(study)85(. J Clin Endocrinol Metab 2016; 101\(1\): 183\22690.)]TJ
ET
endstream
endobj
30 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
BT
0 0 0 1 k
/GS0 gs
/T1_0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 45 54.1778 Tm
(The Southwest Respiratory and Critical Care Chronicles 2017;5\(21\):26\226\
31)Tj
ET
endstream
endobj
31 0 obj
<>/Font<>/ProcSet[/PDF/Text]>>/Subtype/Form>>stream
0 0 0 1 K
0.5 w 4 M 0 j 0 J
/GS0 gs
q 1 0 0 1 45 68.8957 cm
0 0 m
540 0 l
S
Q
10 M
q 1 0 0 1 45 740.2762 cm
0 0 m
540 0 l
S
Q
BT
0 0 0 1 k
/TT0 1 Tf
0 Tc 0 Tw 0 Ts 100 Tz 0 Tr 8 0 0 8 45 751.5262 Tm
[(Metastatic Carcinoid T)73.5(umor with Severe Double V)35.7(alve Disease at Diagnosis: Case Report and Review of Literature)]TJ
/Span<>> BDC
( )Tj
EMC
62.053 0 Td
(Juarez et al.)Tj
ET
endstream
endobj
55 0 obj
<>
endobj
56 0 obj
<>
endobj
57 0 obj
<>stream
H\j@)2&v!>1*;R'?|NvP8붳ioUP7]=?W
(\.ӌ}aA>4Epŵ
\7˵8`v[eTkգ|lS4
eN|.#пDƪFWtKO=BEwT
YL=SQiyBr&gr$|"NBTO}pbLXFF&N}@{Y
;q6ld`.4dVqvqvqvqvqvqv!ǭvNwh
=
,>tFM)_ :
endstream
endobj
58 0 obj
<>stream
HlU TUGAYP .+AE4ʢ)`ѨQu4fT".qC.#,K2M99IN[hEpL'k}cĆ'T8 @zNIN2*#b[ u=c4>/7?W{nbs4&~J #| >c#|=|빀2!>1Iw/?O2W,>o+(E
WjW)XjڠVBb9#A0u8jя۫nPgO~hJ,,nξcf͝]Zlfjݣg:xwԹOWn~{ջO~4x
82Q|2v{ 'cQӦψO9+1ivԹ̛`KҖ.tZ&}mƺq_lemw={e(8XXT|ǎ8Yr9sʿt
^~_7oݾsUP3
܀ЩpJ₸(.FWalelw3y`5ٛ\L&/Si)½x#t~FӤ?mhlO~3u{@#`-MKTUMJTUZT9rbewkJ~N)_ŞD6bcScb7r`is7Ɵ
{P)Rט)T!pPoQ+؇(ukhtL"qxDf!d#`.R cc'r5a1 &pwq(!A!pKp9\f\x>gxxȈ>ߎ8/ v8Th:*x2bY8N'EB9t&_aScfaƥcN_K3qGePc!YۤD_IKԽVr1AvqpW*E=6X=ZOѷD sVsidmv2'0W1^%ِ>I1}TL2]Es`53=̫K~P1swF3a3߸q3>Yّ#5ԞQ0P$J%N2 r4%tzF/YX[ZD-: %/ +↸-\ґ$=d.dLrxj~SuPKUگ.kZK6h_h5Z;C_C!ڰppBZX`b!KXAVGgaTJʓb/]lf/6+EqFfWJd47CBv`%3Dqj$uMIyŷ%sϋ~]dpD*do3XZx taOÞsIEekIb'͕OD#:QE$D찘
E,G̗-zd1ec"
*JAȋhTndRzV0$"d4G"Q(5H7U
}HxǐO)std923rw#dLy7wc:)6+VP\@/X1iy"H0C0߿}z٣{7߮>]:w<۶1[j٩yMlm7Eu>l9G|!97/n-kFQa=iP˴ ɼzNtpǑ3sgE=AY<+-Gt&Vvڮ4s˹ݵw
o^-C7f2Ą":q0E.vbՔErۗƌ3?RڲV߲_da.m5